GCK and maturity-onset diabetes of the young type 2: Studies conducted on MODY2 patients with GCK heterozygous mutation showed increased glucagon secretion from α-cells during the hyperinsulinemic/hypoglycemic clamps, which are stimulated at high glucose concentrations.